Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly LLY revealed 47 unusual trades.
Delving into the details, we found 40% of traders were bullish, while 59% showed bearish tendencies. Out of all the trades we spotted, 13 were puts, with a value of $707,918, and 34 were calls, valued at $3,369,992.
Predicted Price Range
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $300.0 to $840.0 for Eli Lilly during the past quarter.
Volume & Open Interest Trends
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Eli Lilly's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Eli Lilly's substantial trades, within a strike price spectrum from $300.0 to $840.0 over the preceding 30 days.
Eli Lilly Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BEARISH | 04/19/24 | $600.00 | $1.1M | 633 | 306 |
| LLY | CALL | SWEEP | NEUTRAL | 01/19/24 | $350.00 | $359.4K | 371 | 15 |
| LLY | CALL | SWEEP | BULLISH | 01/17/25 | $660.00 | $300.9K | 277 | 60 |
| LLY | CALL | TRADE | NEUTRAL | 01/19/24 | $520.00 | $132.0K | 928 | 20 |
| LLY | PUT | TRADE | BULLISH | 01/16/26 | $840.00 | $130.5K | 1 | 10 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Eli Lilly Standing Right Now?
- Currently trading with a volume of 1,445,405, the LLY's price is down by -0.42%, now at $581.56.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 59 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
